|TRPX -- Israel Stock|| |
null 33.70 0.70 2.12%
Analysis of Therapix Biosciences manpower and management performance can provide insight into Therapix Biosciences stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Therapix Biosciences future performance. Also please take a look at World Market Map
Therapix Biosciences Management Effectiveness
The company has return on total asset (ROA)
of (37.65) %
which means that it has lost $37.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (216.64) %
meaning that it generated substantial loss on money invested by shareholders.
Therapix Biosciences Stakeholders
Therapix Biosciences employes about 9 people. The company is managed by 17 executives with total tenure of roughly 63 years, averanging almost 3.0 years of service per executive having 0.0 employee per reported executive.
|Net Loss Per Employee||851.1 K|
|Net Loss Per Executive||450.6 K|
Also please take a look at World Market Map
. Please also try Piotroski F Score
module to get piotroski f score based on binary analysis strategy of nine different fundamentals.